Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 40Leukemia, Myeloid, Acute 24Congenital Abnormalities 22Leukemia, Lymphocytic, Chronic, B-Cell 16Breast Neoplasms 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 14Lymphoma, Mantle-Cell 12Myelodysplastic Syndromes 11Multiple Myeloma 10Lymphoma, Non-Hodgkin 10Lymphoma, Large B-Cell, Diffuse 10Leukemia, Megakaryoblastic, Acute 10Myeloproliferative Disorders 9Lymphoma 9Leukemia, Monocytic, Acute 9Leukemia, Erythroblastic, Acute 9Burkitt Lymphoma 9Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Chronic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic-Phase 8Waldenstrom Macroglobulinemia 7Sezary Syndrome 7Neoplastic Cells, Circulating 7Mycosis Fungoides 7Melanoma 7Lymphoma, T-Cell, Cutaneous 7Lung Neoplasms 7

Interventions

Brentuximab Vedotin 17fludarabine 9Cyclophosphamide 9dacetuzumab 6Lenalidomide 6Bortezomib 6ruxolitinib 5fludarabine phosphate 5Rituximab 5Melphalan 5Dexamethasone 4Busulfan 4lintuzumab 3Whole-Body Irradiation 3Mycophenolic Acid 3Imatinib Mesylate 3Granulocyte Colony-Stimulating Factor 3Doxorubicin 3Calcium Dobesilate 3Azacitidine 3vosaroxin 2spartalizumab 2ponatinib 2nilotinib 2Vincristine 2Thiotepa 2Tacrolimus 2Sugars 2Stem Cell Transplantation 2Rifampin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hematologic Diseases × Flow Cytometry × Clear all
NCT05819762 2024-12-04

Evaluation of ClearLLab LS Screening Panel

Beckman Coulter, Inc.

Completed
831 enrolled
Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡